The store will not work correctly when cookies are disabled.
(S)-naphthalen-1-yl 5-oxopyrrolidine-2-carboxylate
ID: ALA4241053
Cas Number: 67934-90-1
PubChem CID: 6455651
Max Phase: Preclinical
Molecular Formula: C15H13NO3
Molecular Weight: 255.27
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1CC[C@@H](C(=O)Oc2cccc3ccccc23)N1
Standard InChI: InChI=1S/C15H13NO3/c17-14-9-8-12(16-14)15(18)19-13-7-3-5-10-4-1-2-6-11(10)13/h1-7,12H,8-9H2,(H,16,17)/t12-/m0/s1
Standard InChI Key: KBXKGZPUJFVDLQ-LBPRGKRZSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
7.6353 -16.9093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4525 -16.9093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7069 -16.1326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0439 -15.6505 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3852 -16.1326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6079 -15.8804 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4101 -15.7165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1221 -16.1175 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4013 -14.9075 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1309 -16.9346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4244 -17.3464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4328 -18.1627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1454 -18.5645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8391 -17.3290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8479 -18.1415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5549 -18.5384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2535 -18.1239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2408 -17.3083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5333 -16.9151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
5 6 2 0
3 7 1 6
7 8 1 0
7 9 2 0
8 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 15 1 0
14 10 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 14 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 255.27 | Molecular Weight (Monoisotopic): 255.0895 | AlogP: 2.02 | #Rotatable Bonds: 2 |
Polar Surface Area: 55.40 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.16 | CX Basic pKa: ┄ | CX LogP: 1.90 | CX LogD: 1.90 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.66 | Np Likeness Score: -0.23 |
References
1. Gang FL, Zhu F, Li XT, Wei JL, Wu WJ, Zhang JW.. (2018) Synthesis and bioactivities evaluation of l-pyroglutamic acid analogues from natural product lead., 26 (16): [PMID:30119995] [10.1016/j.bmc.2018.07.041] |